Company profile: bit.bio
1.1 - Company Overview
Company description
- Provider of proprietary cell programming technology and human iPSC-derived cell products for research and drug discovery. Bit.bio develops opti-ox to convert iPSCs into mature, functional human cells and offers ioCells for consistent, scalable supply. The company applies computational principles to biology to code cells for health, including collaboration with The Michael J. Fox Foundation on Parkinson’s research.
Products and services
- Collaboration with The Michael J. Fox Foundation: Develops human cell products for Parkinson’s disease research and drug discovery, enabling studies with disease-relevant human cells
- Parkinson’s-focused
- IoCells products: Delivers human iPSC-derived cell products for research and drug discovery, offering consistency and scalability across batches for reliable laboratory use
- Scalable
- Opti-ox technology: Cell programming technology used to convert induced pluripotent stem cells into mature, functional human cells, supporting Bit.bio’s mission of coding cells for health
- Proprietary
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to bit.bio
Kendall Research Systems
HQ: United States
Website
- Description: Provider of pioneering novel tools for neuroscience discovery using optogenetic techniques, operating as an R&D think tank developing technologies in bioinstrumentation, ultra-low power computation, and communications links; originated in 2011 as an optical neural interface technology spin-out from MIT's Synthetic Neurobiology Lab.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kendall Research Systems company profile →
Scioto Biosciences
HQ: United States
Website
- Description: Provider of Activated Bacterial Therapeutics, including SB-121, a formulation of L. reuteri with Sephadex and maltose designed to deliver activated probiotic bacteria to the gastrointestinal tract for treating autism spectrum disorder and potentially other GI disorders, and an ABT platform that enhances delivery and efficacy of live bacterial therapeutics for GI health and diseases affecting the gut-brain axis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Scioto Biosciences company profile →
Merlin Diagnostika
HQ: Germany
Website
- Description: Provider of microbiological diagnostics solutions, developing and producing products for automated identification and susceptibility determination of bacteria and yeasts. Serves domestic routine laboratories in human and veterinary fields and has an international customer base.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Merlin Diagnostika company profile →
Microbiome Insights
HQ: Canada
Website
- Description: Provider of end-to-end microbiome DNA sequencing services and state-of-the-art bioinformatic analysis. Offerings include 16S V4 amplicon sequencing for taxonomic profiling, shotgun metagenomic sequencing for species-level and functional insights, short-chain fatty acid analysis in stool, qPCR for absolute abundance, and comprehensive bioinformatics processing and reporting.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Microbiome Insights company profile →
Bruker
HQ: United States
Website
- Description: Provider of analytical and medical instruments covering NMR, ESR, FT-IR and X-ray spectroscopy. MALDI Imaging to visualize molecular distribution in tissue sections; neofleX MALDI-TOF/TOF benchtop MS for protein and peptide analysis; Q6 NEWTON optical emission spectrometer for precise metal and alloy composition; BEAM FT-NIR for real-time process control of solid and semi-solid materials; and Dektak Pro profilometer for semiconductor surfaces.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bruker company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for bit.bio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to bit.bio
2.2 - Growth funds investing in similar companies to bit.bio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for bit.bio
4.2 - Public trading comparable groups for bit.bio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →